サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629319

吸入カプセル市場：製剤別、用途別、放出メカニズム別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）

Inhalation Capsules Market, By Formulation, By Application, By Release Mechanism, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 288 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
吸入カプセル市場：製剤別、用途別、放出メカニズム別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）
出版日: 2024年12月04日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

吸入カプセル市場規模は2023年に8億3,190万米ドルとなり、2024年から2032年にかけてCAGR 6.50%で拡大

吸入カプセル市場 - 市場力学

呼吸器疾患の有病率の上昇が市場需要を促進

呼吸器疾患の有病率の上昇は、医薬品市場における吸入カプセルの需要を促進する重要な要因です。喘息、慢性閉塞性肺疾患（COPD）、その他の肺関連疾患などの呼吸器疾患は、大気汚染、喫煙、高齢化、遺伝的素因などの要因により、より一般的になっています。これらの疾患は長期的な管理を必要とすることが多く、吸入療法は最も効果的な治療法のひとつと考えられており、迅速かつ的を絞った緩和を提供しています。

呼吸器疾患の増加に伴い、より効果的で簡便な治療法に対するニーズも高まっています。正確な投与量と効率的なドラッグデリバリーを肺に直接供給する吸入カプセルは、喘息やCOPDのような症状の患者に好まれる選択肢になりつつあります。これらのカプセルは肺での薬物吸収を良くし、治療成績を向上させ、経口治療で見られる全身性の副作用の頻度を減らすことができます。世界保健機関（WHO）によると、COPDは2030年までに世界第3位の死因になると予想されています。このようなCOPD患者の増加は、喘息の有病率の増加とともに、効果的な吸入療法への需要を煽っています。その結果、吸入カプセル市場は、製薬会社がこれらの広範な呼吸器疾患に対処するための革新的な解決策を開発し続けているため、大きな成長を遂げると予測されています。

吸入カプセル市場 - 主要洞察

  • 当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024年～2032年）に約6.50%のCAGRで毎年成長すると予測されています。
  • 製剤セグメンテーションに基づくと、粉末吸入カプセルは2023年に最大市場シェアを示すと予測されました。
  • 用途別では、喘息が2023年の主要セグメントでした。
  • 地域別では、北米が2023年に主要な収益源となりました。

吸入カプセル市場 - セグメンテーション分析：

吸入カプセルの世界市場は、製剤、用途、放出メカニズム、地域に基づいてセグメント化されます。

市場は製剤別に粉末吸入カプセル、液体充填カプセルに分類されます。粉末吸入カプセルは、いくつかの重要な要因により市場を独占しています。第一に、喘息やCOPDのような症状で最も必要とされる肺への効率的なドラッグデリバリーが可能です。微粉末は肺の奥深くまで確実に浸透し、薬効を最大化します。

市場は用途によって、喘息、慢性閉塞性肺疾患、肺感染症、肺高血圧症に分類されます。喘息は市場を独占しており、その高い有病率、環境的誘因、現在進行中の治療の進歩により、予測期間中もその優位性を維持する可能性が高いです。世界中で2億6,000万人以上が喘息に苦しんでおり、最も一般的な慢性呼吸器疾患の1つとなっています。この患者数の多さが、吸入療法を含む喘息治療に対する継続的な需要を後押ししています。

吸入カプセル市場 - 地理的洞察

吸入カプセル市場は、呼吸器疾患の有病率の増加と先進ドラッグデリバリーシステムの採用増加により、様々な地域で成長を遂げています。北米は、確立されたヘルスケアインフラ、高医療費、喘息やCOPDのような呼吸器疾患の患者人口の多さによって、大きなシェアを占めています。欧州もまた、高齢化人口の増加と強力なヘルスケアシステムが吸入療法の採用を支えており、重要な役割を果たしています。アジア太平洋では、呼吸器疾患の罹患率の上昇、ヘルスケアインフラの拡大、医療アクセスの改善を目指した政府の取り組みに後押しされ、市場の急成長が見込まれています。ラテンアメリカでは喫煙率の上昇、都市化、大気汚染により需要が増加しており、中東とアフリカでは呼吸器疾患の負担が増加しているが、高度なヘルスケアへのアクセスは限られています。しかし、これらの地域ではヘルスケアの改善が進んでおり、今後の市場成長の原動力になると予想されます。

吸入カプセル市場 - 競合情勢：

吸入カプセル市場は、効果的な呼吸器治療に対する需要の高まりとドラッグデリバリー技術の継続的な進歩により、競争が激しくなっています。各社は革新的な吸入製品、特にバイオアベイラビリティの向上と作用発現の迅速化を実現する改良型製剤のドライパウダー吸入器（DPI）の開発に注力しています。製薬会社、調査機関、ヘルスケアプロバイダー間の戦略的パートナーシップやコラボレーションは、市場へのリーチを拡大し、製品提供を強化する上で極めて重要です。さらに、市場競争力を維持し、製品の入手可能性を維持するためには、規制遵守を確保し、さまざまな地域の保健当局から承認を得ることが不可欠であり、市場の成長をさらに促進しています。

目次

第1章 吸入カプセル市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 吸入カプセルの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 吸入カプセル産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 吸入カプセル市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 吸入カプセル市場情勢

  • 吸入カプセル市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 吸入カプセル市場 - 製剤別

  • 概要
    • セグメントシェア分析 - 製剤別
    • 粉末吸入カプセル
    • 液体充填カプセル

第8章 吸入カプセル市場 - 用途別

  • 概要
    • セグメントシェア分析 - 用途別
    • 喘息
    • 慢性閉塞性肺疾患
    • 肺感染症
    • 肺高血圧症

第9章 吸入カプセル市場 - 放出メカニズム別

  • 概要
    • セグメントシェア分析 - 放出メカニズム別
    • 即時リリース
    • 制御放出

第10章 吸入カプセル市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 吸入カプセル業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • AstraZeneca PLC
    • GlaxoSmithKline plc
    • Novartis International AG
    • Cipla Limited
    • Boehringer Ingelheim GmbH
    • Merck &Co., Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Lupin Pharmaceuticals, Inc.
    • UCB SA
    • Hovione
    • Dr. Reddy's Laboratories Ltd.
    • Laboratorios Farmaceuticos Rovi, SA
    • Vectura Group plc
    • MannKind Corporation
    • Catalent Pharma Solutions
    • Pfizer Inc.
    • Ferring Pharmaceuticals Inc.
    • その他

第12章 アナリストの全方位展望

目次
Product Code: ANV4501

REPORT HIGHLIGHT

Inhalation Capsules Market size was valued at USD 831.90 Million in 2023, expanding at a CAGR of 6.50% from 2024 to 2032.

Inhalation capsules are specialized pharmaceutical capsules containing powdered medication intended for delivery directly into the lungs through inhalation. These capsules are used with inhalation devices and are designed to ensure the medication reaches the lungs efficiently. This method of drug delivery is particularly important for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), where localized treatment is crucial. The inhalation route allows for faster onset of action compared to oral medications, as it bypasses the digestive system, providing quicker relief. Additionally, it reduces the risk of systemic side effects since the drug is targeted directly to the lungs, improving the overall effectiveness and safety of treatment.

Inhalation Capsules Market- Market Dynamics

Rising prevalence of respiratory diseases to propel market demand

The rising prevalence of respiratory diseases is a significant factor driving the demand for inhalation capsules in the pharmaceutical market. Respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and other lung-related conditions, have become more common due to factors like air pollution, smoking, aging populations, and genetic predispositions. These conditions often require long-term management, and inhalation therapies are considered one of the most effective treatment options, offering rapid and targeted relief.

As respiratory diseases grow in number, the need for more effective and convenient treatments also rises. Inhalation capsules, which provide a precise dosage and efficient drug delivery directly to the lungs, are becoming a preferred choice for patients with conditions like asthma and COPD. These capsules allow for better drug absorption in the lungs, improving therapeutic outcomes and reducing the frequency of systemic side effects seen with oral treatments. One statistic that highlights this trend is that, according to the World Health Organization (WHO), COPD is expected to become the third leading cause of death worldwide by 2030. This increase in COPD cases, alongside the growing asthma prevalence, fuels the demand for effective inhalation therapies. As a result, the inhalation capsule market is projected to experience significant growth as pharmaceutical companies continue to develop innovative solutions to address these widespread respiratory conditions.

Inhalation Capsules Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.50% over the forecast period (2024-2032)
  • Based on formulation segmentation, Powdered Inhalation Capsules was predicted to show maximum market share in the year 2023
  • Based on application segmentation, Asthma was the leading segment in 2023
  • On the basis of region, North America was the leading revenue generator in 2023

Inhalation Capsules Market- Segmentation Analysis:

The Global Inhalation Capsules Market is segmented on the basis of Formulation, Application, Release Mechanism and Region.

The market is divided into three categories based on formulation: powdered inhalation capsules, and liquid-filled capsules. The powdered inhalation capsules sector dominates the market. The powdered inhalation capsules sector dominates the market due to several key factors. First, they provide efficient drug delivery directly to the lungs, where they are most needed for conditions like asthma and COPD. The fine powder ensures deep lung penetration, maximizing the drug's effectiveness.

The market is divided into two categories based on application: asthma, chronic obstructive pulmonary disease, pulmonary infections, and pulmonary hypertension. Asthma dominates the market and is likely to maintain its dominance during the forecast period due to its high prevalence, environmental triggers, and ongoing treatment advancements. Over 260 million people worldwide suffer from asthma, making it one of the most common chronic respiratory diseases. This large patient population drives continuous demand for asthma treatments, including inhalation therapies

Inhalation Capsules Market- Geographical Insights

The inhalation capsules market is experiencing growth across various regions due to the increasing prevalence of respiratory diseases and the rising adoption of advanced drug delivery systems. North America holds a significant share, driven by a well-established healthcare infrastructure, high healthcare spending, and a large patient population with respiratory conditions like asthma and COPD. Europe also plays a key role, with a growing aging population and strong healthcare systems supporting the adoption of inhalation therapies. In Asia-Pacific, rapid market growth is expected, fueled by rising respiratory disease incidences, expanding healthcare infrastructure, and government initiatives aimed at improving healthcare access. Latin America is seeing increased demand due to rising smoking rates, urbanization, and air pollution, while the Middle East and Africa face a growing respiratory disease burden but have more limited access to advanced healthcare. However, ongoing healthcare improvements in these regions are expected to drive future market growth.

Inhalation Capsules Market- Competitive Landscape:

The inhalation capsules market is highly competitive, driven by the increasing demand for effective respiratory treatments and continuous advancements in drug delivery technologies. Companies are focusing on developing innovative inhalation products, particularly dry powder inhalers (DPIs), with improved formulations that offer better bioavailability and faster onset of action. Strategic partnerships and collaborations between pharmaceutical companies, research organizations, and healthcare providers are crucial in expanding market reach and enhancing product offerings. Additionally, ensuring regulatory compliance and obtaining approvals from health authorities across different regions is vital for market players to stay competitive and maintain product availability, further fueling the growth of the market.

Recent Developments:

  • In February 2024, Catalent announced the addition of potent capsule filling capabilities for inhaled dry powders at its Boston, MA facility. This expansion aims to meet the growing demand for complex drug delivery solutions in the pharmaceutical industry. The new capabilities will support clients developing inhalation therapies, enhancing Catalent's offerings in the field of biologics and advanced drug formulations.
  • In August 2023, Lupin launched its Tiotropium Dry Powder Inhaler in the United States for the treatment of COPD, expanding its respiratory portfolio with a cost-effective solution aimed at improving patient access to this critical therapy.
  • In June 2024, Verona Pharma announced the U.S. FDA approval of Ohtuvayre(TM) (ensifentrine), a novel treatment for chronic obstructive pulmonary disease (COPD), marking a significant milestone in the company's respiratory therapeutics pipeline. The approval is expected to enhance the management of COPD symptoms by combining both bronchodilator and anti-inflammatory properties in a single inhaled therapy, offering a new option for patients who are not adequately controlled with current treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INHALATION CAPSULES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis International AG
  • Cipla Limited
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Lupin Pharmaceuticals, Inc.
  • UCB S.A.
  • Hovione
  • Dr. Reddy's Laboratories Ltd.
  • Laboratorios Farmaceuticos Rovi, S.A.
  • Vectura Group plc
  • MannKind Corporation
  • Catalent Pharma Solutions
  • Pfizer Inc.
  • Ferring Pharmaceuticals Inc.
  • Others

GLOBAL INHALATION CAPSULES MARKET, BY FORMULATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Powdered Inhalation Capsules
  • Liquid-filled Capsules

GLOBAL INHALATION CAPSULES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Infections
  • Pulmonary Hypertension

GLOBAL INHALATION CAPSULES MARKET, BY RELEASE MECHANISM- MARKET ANALYSIS, 2019 - 2032

  • Immediate Release
  • Controlled Release

GLOBAL INHALATION CAPSULES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Inhalation Capsules Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Inhalation Capsules Market Snippet by Formulation
    • 2.1.2. Inhalation Capsules Market Snippet by Application
    • 2.1.3. Inhalation Capsules Market Snippet by Release Mechanism
    • 2.1.4. Inhalation Capsules Market Snippet by Country
    • 2.1.5. Inhalation Capsules Market Snippet by Region
  • 2.2. Competitive Insights

3. Inhalation Capsules Key Market Trends

  • 3.1. Inhalation Capsules Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Inhalation Capsules Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Inhalation Capsules Market Opportunities
  • 3.4. Inhalation Capsules Market Future Trends

4. Inhalation Capsules Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Inhalation Capsules Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Inhalation Capsules Market Landscape

  • 6.1. Inhalation Capsules Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Inhalation Capsules Market - By Formulation

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Formulation, 2023 & 2032 (%)
    • 7.1.2. Powdered Inhalation Capsules
    • 7.1.3. Liquid-filled Capsules

8. Inhalation Capsules Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Asthma
    • 8.1.3. Chronic Obstructive Pulmonary Disease
    • 8.1.4. Pulmonary Infections
    • 8.1.5. Pulmonary Hypertension

9. Inhalation Capsules Market - By Release Mechanism

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Release Mechanism, 2023 & 2032 (%)
    • 9.1.2. Immediate Release
    • 9.1.3. Controlled Release

10. Inhalation Capsules Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Inhalation Capsules Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Inhalation Capsules Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Inhalation Capsules Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Inhalation Capsules Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Inhalation Capsules Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Formulation, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Release Mechanism, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Inhalation Capsules Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca PLC
    • 11.2.2. GlaxoSmithKline plc
    • 11.2.3. Novartis International AG
    • 11.2.4. Cipla Limited
    • 11.2.5. Boehringer Ingelheim GmbH
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. Sun Pharmaceutical Industries Ltd.
    • 11.2.8. Teva Pharmaceutical Industries Ltd.
    • 11.2.9. Lupin Pharmaceuticals, Inc.
    • 11.2.10. UCB S.A.
    • 11.2.11. Hovione
    • 11.2.12. Dr. Reddy's Laboratories Ltd.
    • 11.2.13. Laboratorios Farmaceuticos Rovi, S.A.
    • 11.2.14. Vectura Group plc
    • 11.2.15. MannKind Corporation
    • 11.2.16. Catalent Pharma Solutions
    • 11.2.17. Pfizer Inc.
    • 11.2.18. Ferring Pharmaceuticals Inc.
    • 11.2.19. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us